stella
beta
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. — Stella
Home
/
Active Systemic Juvenile Idiopathic Arthritis
/
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
View on ClinicalTrials.gov
Recruiting
Back to Active Systemic Juvenile Idiopathic Arthritis trials
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(10 sites)
China
Children's Hospital Affiliated to Capital Medical University, Beijing, Benjing
Children's Hospital Affiliated to Chongqing Medical University, Chongqing, Chongqing Municipality
Hunan Children's Hospital, Changsha, Hunan
Children's Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu
Children's Hospital of Soochow University, Suzhou, Jiangsu
Affiliated Pediatric Hospital of Fudan University, Shanghai, Shanghai Municipality
Xi'an Children's Hospital, Xi’an, Shanxi
Chengdu Women and Children's Central Hospital, Chengdu, Sichuan
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang